How to find a reliable supplier, what quality documentation to expect, what current prices look like, and the red flags that separate serious suppliers from the rest.
Retatrutide is not just another GLP-1 peptide to add to a list. It's a structurally more complex compound — a triple agonist requiring more sophisticated synthesis than semaglutide or tirzepatide — and the research peptide market for it is correspondingly smaller. As of mid-2026, fewer US suppliers carry it, quality varies more than with established compounds, and the price-per-mg is higher than the GLP-1 market average.
That means the standard advice for buying research peptides applies here with extra weight. The steps you might shortcut with a well-established compound like BPC-157 — checking lot-specific CoAs, verifying the testing lab, confirming mass spectrometry — matter more with retatrutide, where supply chains are newer and quality hasn't been as widely validated.
1Check for a third-party Certificate of Analysis — and confirm it's recent
A CoA should be on file for retatrutide specifically, from a recognized independent lab. "Recent" means within the last 12 months at most — ideally within 6 months. Any supplier who links to a CoA dated 2024 or earlier for 2026 inventory has a documentation gap worth questioning.
Recognized independent testing labs: Janoshik Analytical, Colmaric Analyticals, Intertek. Avoid CoAs from in-house or unspecified labs — these are not independent.
2Confirm the CoA covers identity — not just purity
For retatrutide specifically, a purity percentage alone is not sufficient documentation. Because retatrutide is a newer compound with fewer reference standards in the supply chain, identity confirmation via mass spectrometry is more important here than for established peptides. The expected molecular weight is approximately 4,859 Da — a CoA should show the observed m/z value and confirm it matches.
A CoA that shows "99% purity" without identity confirmation tells you something is 99% present — it does not confirm what that something is.
3Match the lot number to your order
Ask whether the CoA on the website corresponds to the specific batch you'll receive. Some suppliers maintain one standing CoA document for a compound and apply it to multiple production runs. Lot-specific documentation is a higher standard — and for a compound like retatrutide where synthesis complexity is higher, it's worth asking for.
4Check the supplier's track record specifically on retatrutide
A supplier with an excellent reputation for BPC-157 or semaglutide is not automatically reliable on retatrutide — they may have introduced it recently and not yet have the same quality control depth. Look for community test results (not just vendor-provided CoAs) on retatrutide specifically. Peptide forums and aggregator sites like Finnrick can surface independent testing data that didn't come from the supplier.
5Compare price-per-mg, not just vial price
Retatrutide comes in multiple sizes (2mg, 5mg, 10mg, and occasionally 20–60mg bulk). A 10mg vial at $165 is $16.50/mg. A 5mg vial at $90 is $18/mg. Larger sizes almost always have better per-mg economics — and with a compound priced at these levels, the difference adds up quickly. Use our live retatrutide price comparison to see current per-mg costs across all tracked suppliers.
Based on current data from tracked US suppliers:
| Size | Typical Price Range | Cost Per mg |
|---|---|---|
| 2mg vial | $35–$55 | $17–$28/mg |
| 5mg vial | $75–$100 | $15–$20/mg |
| 10mg vial | $140–$175 | $14–$17.50/mg |
| 20mg vial | $250–$320 | $12.50–$16/mg |
| 60mg bulk | $380–$480 | $6–$8/mg |
Prices are higher than semaglutide or tirzepatide research grade, reflecting both the compound's complexity and the limited number of suppliers. As Phase 3 trial results publish and more suppliers enter the market, pricing will likely compress — as happened with tirzepatide over 2024–2025.
If a supplier's retatrutide price is dramatically lower than the benchmarks above — say, $50 for a 10mg vial — treat it as a quality signal, not a deal. Complex peptides priced far below market either reflect quality compromises or are mislabeled product. The synthesis cost floor for a legitimate 10mg retatrutide vial from a US supplier does not permit pricing near semaglutide levels.
Retatrutide (LY3437943) is being developed by Eli Lilly and is currently in Phase 3 clinical trials as of 2026. It is not approved by the FDA for any indication. The research peptide sold by US suppliers is synthesized independently of Eli Lilly and is sold under the research-use-only framework that applies to unapproved investigational compounds.
Phase 2 data (published 2023) showed average weight loss of 17.5% at 48 weeks at the 4mg weekly dose, and 24.2% at the 12mg dose — exceeding both semaglutide (STEP-1: ~14.9%) and tirzepatide (SURMOUNT-1: ~20.9% at max dose). These figures are from the Phase 2 trial and should be understood as preliminary until Phase 3 results publish.
For researchers, this context matters: the scientific interest in this compound is high and justified, but it also means the supply chain is younger and quality documentation is less mature than for established compounds.
Retatrutide is not a scheduled substance in the US, making it legal to purchase for research purposes. However, regulations in this space can change — particularly as compounds approach or receive FDA approval. Stay current on FDA guidance and applicable state regulations in your jurisdiction. The research-use-only designation does not authorize self-administration or therapeutic use.
For research reference: lyophilized (freeze-dried) retatrutide is typically reconstituted with bacteriostatic water using 1–2ml per vial depending on the vial size and target concentration. Standard research peptide storage applies — lyophilized vials should be stored below -20°C before reconstitution and refrigerated (2–8°C) after reconstitution. Avoid multiple freeze-thaw cycles.
Bacteriostatic water, insulin syringes (29–31 gauge, 1cc), and alcohol prep pads are available from research supply vendors. These are entirely standard and widely available.
BetterNewLives.com tracks current retatrutide prices across US suppliers with automated updates. The tool shows price per vial and cost per mg side by side, so you can evaluate value across different sizes at a glance. Where available, it also links to third-party vendor ratings from Finnrick.
Live price comparison across tracked US suppliers — updated automatically with per-mg cost breakdowns and supplier rating links.
View Retatrutide Prices →